Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry

Advanced Drug Delivery Reviews

Volumn 106, Issue , 2016, Pages 3-26

  Ni, Rong ^a   Zhou, Junli ^a   Hossain, Naushad ^a   Chau, Ying ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Bionanotechnology; Gene therapy; Nanocarrier; Non viral vector; Self assembly peptide; Viral mimicry

Indexed keywords

BIOMOLECULES; DRUG THERAPY; GENE THERAPY; MOLECULAR BIOLOGY; NUCLEIC ACIDS; SELF ASSEMBLY; VECTORS;

BIONANOTECHNOLOGY; NANOCARRIERS; NONVIRAL VECTORS; SELF-ASSEMBLY PEPTIDE; VIRAL MIMICRY;

VIRUSES;

CAPSID PROTEIN; NUCLEIC ACID;

CELL MIGRATION; CYTOPLASM; DNA TRANSFER; ENDOSOME; HUMAN; LIGAND BINDING; NONHUMAN; NUCLEIC ACID TRANSPORT; PRIORITY JOURNAL; REVIEW; RNA TRANSPORT; VIRAL GENE DELIVERY SYSTEM; VIRAL MIMICRY; VIRAL PHENOMENA AND FUNCTIONS; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME; VIRUS MORPHOLOGY; ADMINISTRATION AND DOSAGE; ANIMAL; BIOMIMETICS; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; PROCEDURES; VIRUS;

ANIMALS; BIOMIMETICS; GENETIC THERAPY; GENETIC VECTORS; HUMANS; NUCLEIC ACIDS; TRANSFECTION; VIRUSES;

EID: 84994339428     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.07.005     Document Type: Review

References (336)

1. [1] Thomas, C.E., Ehrhardt, A., Kay, M.A., Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4 (2003), 346–358.
2. [2] Carter, B.J., Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. 16 (2005), 541–550.
3. [3] Young, L.S., Searle, P.F., Onion, D., Mautner, V., Viral gene therapy strategies: from basic science to clinical application. J. Pathol. 208 (2006), 299–318.
4. [4] Bouard, D., Alazard-Dany, N., Cosset, F.L., Viral vectors: from virology to transgene expression. Br. J. Pharmacol. 157 (2009), 153–165.
5. [5] Yin, H., Kanasty, R.L., Eltoukhy, A.A., Vegas, A.J., Dorkin, J.R., Anderson, D.G., Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15 (2014), 541–555.
6. [6] Ramamoorth, M., Narvekar, A., Non viral vectors in gene therapy — an overview. J. Clin. Diagn. Res. 9 (2015), GE01–GE06.
7. [7] Park, T.G., Jeong, J.H., Kim, S.W., Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 58 (2006), 467–486.
8. [8] Schaffert, D., Wagner, E., Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther. 15 (2008), 1131–1138.
9. [9] Santos, J.L., Oliveira, H., Pandita, D., Rodrigues, J., Pego, A.P., Granja, P.L., Tomas, H., Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J. Control. Release 144 (2010), 55–64.
10. [10] Lungwitz, U., Breunig, M., Blunk, T., Gopferich, A., Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60 (2005), 247–266.
11. [11] Modra, K., Dai, S., Zhang, H., Shi, B.Y., Bi, J.X., Polycation-mediated gene delivery: challenges and considerations for the process of plasmid DNA transfection. Eng. Life Sci. 15 (2015), 489–498.
12. [12] Luo, D., Saltzman, W.M., Synthetic DNA delivery systems. Nat. Biotechnol. 18 (2000), 33–37.
13. [13] Wagner, E., Application of membrane-active peptides for nonviral gene delivery. Adv. Drug Deliv. Rev. 38 (1999), 279–289.
14. [14] Wagner, E., Plank, C., Zatloukal, K., Cotten, M., Birnstiel, M.L., Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin–polylysine–DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 7934–7938.
15. [15] Varkouhi, A.K., Scholte, M., Storm, G., Haisma, H.J., Endosomal escape pathways for delivery of biologicals. J. Control. Release 151 (2011), 220–228.
16. [16] Ye, S.F., Tian, M.M., Wang, T.X., Ren, L., Wang, D., Shen, L.H., Shang, T., Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. Nanomedicine 8 (2012), 833–841.
17. [17] Lange, A., Mills, R.E., Lange, C.J., Stewart, M., Devine, S.E., Corbett, A.H., Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282 (2007), 5101–5105.
18. [18] Park, E., Ch, H.B., Takimoto, K., Effective gene delivery into adipose-derived stem cells: transfection of cells in suspension with the use of a nuclear localization signal peptide-conjugated polyethylenimine. Cytotherapy 17 (2015), 536–542.
19. [19] Ross, N.L., Sullivan, M.O., Importin-4 regulates gene delivery by enhancing nuclear retention and chromatin deposition by polyplexes. Mol. Pharm. 12 (2015), 4488–4497.
20. [20] Zhang, Y., Wang, Z.J., Gemeinhart, R.A., Progress in microRNA delivery. J. Control. Release 172 (2013), 962–974.
21. [21] Sander, J.D., Joung, J.K., CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32 (2014), 347–355.
22. [22] Pan, J.H., Dong, L.P., Lin, L., Ochoa, W.F., Sinkovits, R.S., Havens, W.M., Nibert, M.L., Baker, T.S., Ghabrial, S.A., Tao, Y.Z.J., Atomic structure reveals the unique capsid organization of a dsRNA virus, Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 4225–4230.
23. [23] Pornillos, O., Ganser-Pornillos, B.K., Kelly, B.N., Hua, Y., Whitby, F.G., Stout, C.D., Sundquist, W.I., Hill, C.P., Yeager, M., X-ray structures of the hexameric building block of the HIV capsid. Cell 137 (2009), 1282–1292.
24. [24] Mortuza, G.B., Haire, L.F., Stevens, A., Smerdon, S.J., Stoye, J.P., Taylor, I.A., High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431 (2004), 481–485.
25. [25] Kamimura, K., Suda, T., Zhang, G., Liu, D., Advances in gene delivery systems. Pharm. Med. 25 (2011), 293–306.
26. [26] Nayerossadat, N., Maedeh, T., Ali, P.A., Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res., 1, 2012, 27.
27. [27] Collins, M., Thrasher, A., Gene therapy: progress and predictions. Proc. R. Soc. Lond. B Biol. Sci., 282, 2015.
28. [28] Daka, A., Peer, D., RNAi-based nanomedicines for targeted personalized therapy. Adv. Drug Deliv. Rev. 64 (2012), 1508–1521.
29. [29] Myles, K.M., Wiley, M.R., Morazzani, E.M., Adelman, Z.N., Alphavirus-derived small RNAs modulate pathogenesis in disease vector mosquitoes. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 19938–19943.
30. [30] Usme-Ciro, J.A., Campillo-Pedroza, N., Almazan, F., Gallego-Gomez, J.C., Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs. Virol. J., 10, 2013.
31. [31] Strauss, J.H., Wang, K.S., Schmaljohn, A.L., Kuhn, R.J., Strauss, E.G., Host-cell Receptors for Sindbis Virus. 1994, Springer.
32. [32] Gamino, V., Höfle, U., Pathology and tissue tropism of natural West Nile virus infection in birds: a review. Vet. Res., 44, 2013, 39.
33. [33] Trobridge, G.D., Wu, R.A., Hansen, M., Ironside, C., Watts, K.L., Olsen, P., Beard, B.C., Kiem, H.-P., Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol. Ther. 18 (2010), 725–733.
34. [34] Hidari, K.I.P.J., Suzuki, T., Dengue virus receptor. Trop. Med. Health 39 (2011), 37–43.
35. [35] Aleksandrowicz, P., Marzi, A., Biedenkopf, N., Beimforde, N., Becker, S., Hoenen, T., Feldmann, H., Schnittler, H.J., Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204:Suppl. 3 (2011), S957–S967.
36. [36] Martines, R.B., Ng, D.L., Greer, P.W., Rollin, P.E., Zaki, S.R., Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J. Pathol. 235 (2015), 153–174.
37. [37] Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., Rouille, Y., Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80 (2006), 6964–6972.
38. [38] Grove, J., Marsh, M., The cell biology of receptor-mediated virus entry. J. Cell Biol. 195 (2011), 1071–1082.
39. [39] Schnell, M.J., McGettigan, J.P., Wirblich, C., Papaneri, A., The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Microbiol. 8 (2010), 51–61.
40. [40] Langevin, C., Jaaro, H., Bressanelli, S., Fainzilber, M., Tuffereau, C., Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 277 (2002), 37655–37662.
41. [41] Piccinotti, S., Kirchhausen, T., Whelan, S.P.J., Uptake of rabies virus into epithelial cells by clathrin-mediated endocytosis depends upon actin. J. Virol. 87 (2013), 11637–11647.
42. [42] Chahroudi, A., Chavan, R., Koyzr, N., Waller, E.K., Silvestri, G., Feinberg, M.B., Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 79 (2005), 10397–10407.
43. [43] Zhang, Y., Bergelson, J.M., Adenovirus receptors. J. Virol. 79 (2005), 12125–12131.
44. [44] Mercer, J., Helenius, A., Virus entry by macropinocytosis. Nat. Cell Biol. 11 (2009), 510–520.
45. [45] Liu, Y., Joo, K.I., Wang, P., Endocytic processing of adeno-associated virus type 8 vectors for transduction of target cells. Gene Ther. 20 (2013), 308–317.
46. [46] Pelkmans, L., J.u.r. Kartenbeck, A. Helenius, Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3 (2001), 473–483.
47. [47] Wang, X., Huong, S.M., Chiu, M.L., Raab-Traub, N., Huang, E.S., Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424 (2003), 456–461.
48. [48] Li, W., The hepatitis B virus receptor. Annu. Rev. Cell Dev. Biol. 31 (2015), 125–147.
49. [49] Reske, A., Pollara, G., Krummenacher, C., Chain, B.M., Katz, D.R., Understanding HSV-1 entry glycoproteins. Rev. Med. Virol. 17 (2007), 205–215.
50. [50] Wilen, C.B., Tilton, J.C., Doms, R.W., HIV: cell binding and entry. Cold Spring Harb. Perspect. Med., 2, 2012.
51. [51] Chen, Z., Zhou, P., Ho, D.D., Landau, N.R., Marx, P.A., Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71 (1997), 2705–2714.
52. [52] Owen, S.M., Masciotra, S., Novembre, F., Yee, J., Switzer, W.M., Ostyula, M., Lal, R.B., Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells. J. Virol. 74 (2000), 5702–5708.
53. [53] Luo, M., Influenza Virus Entry. Rossmann, G.M., Rao, B.V., (eds.) Viral Molecular Machines, 2012, Springer US, Boston, MA, 201–221.
54. [54] Kegel, W.K., van der Schoot, P., Physical regulation of the self-assembly of tobacco mosaic virus coat protein. Biophys. J. 91 (2006), 1501–1512.
55. [55] Wynne, S.A., Crowther, R.A., Leslie, A.G., The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3 (1999), 771–780.
56. [56] Cheng, S., Brooks, C.L. III, Viral capsid proteins are segregated in structural fold space. PLoS Comput. Biol., 9, 2013, e1002905.
57. [57] Zhao, G., Perilla, J.R., Yufenyuy, E.L., Meng, X., Chen, B., Ning, J., Ahn, J., Gronenborn, A.M., Schulten, K., Aiken, C., Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics. Nature 497 (2013), 643–646.
58. [58] Campbell, E.M., Hope, T.J., HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat. Rev. Microbiol. 13 (2015), 471–483.
59. [59] Liddington, R.C., Yan, Y., Moulai, J., Sahli, R., Benjamin, T.L., Harrison, S.C., Structure of Simian virus-40 at 3.8-a resolution. Nature 354 (1991), 278–284.
60. [60] Stehle, T., Gamblin, S.J., Yan, Y., Harrison, S.C., The structure of simian virus 40 refined at 3.1 A resolution. Structure 4 (1996), 165–182.
61. [61] Oppenheim, A., Ben-Nun-Shaul, O., Mukherjee, S., Abd-El-Latif, M., SV40 assembly in vivo and in vitro. Comput. Math. Methods Med. 9 (2008), 265–276.
62. [62] Sun, S.Y., Rao, V.B., Rossmann, M.G., Genome packaging in viruses. Curr. Opin. Struct. Biol. 20 (2010), 114–120.
63. [63] del Alamo, M., Mateu, M.G., Electrostatic repulsion, compensatory mutations, and long-range non-additive effects at the dimerization interface of the HIV capsid protein. J. Mol. Biol. 345 (2005), 893–906.
64. [64] Kegel, W.K., van der Schoot, P., Physical regulation of the self-assembly of tobacco mosaic virus coat protein. Biophys. J. 91 (2006), 1501–1512.
65. [65] Belyi, V.A., Muthukumar, M., Electrostatic origin of the genome packing in viruses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 17174–17178.
66. [66] Garmann, R.F., Comas-Garcia, M., Koay, M.S., Cornelissen, J.J., Knobler, C.M., Gelbart, W.M., Role of electrostatics in the assembly pathway of a single-stranded RNA virus. J. Virol. 88 (2014), 10472–10479.
67. [67] Zhang, X.F., Zhao, X.F., Zhang, Y.J., Niu, S.F., Qu, F., Zhang, Y.L., Han, C.G., Yu, J.L., Li, D.W., N-terminal basic amino acid residues of Beet black scorch virus capsid protein play a critical role in virion assembly and systemic movement. Virol. J., 10, 2013.
68. [68] Ruigrok, R.W., Crepin, T., Kolakofsky, D., Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr. Opin. Microbiol. 14 (2011), 504–510.
69. [69] Perlmutter, J.D., Perkett, M.R., Hagan, M.F., Pathways for virus assembly around nucleic acids. J. Mol. Biol. 426 (2014), 3148–3165.
70. [70] Hütter, S., Zurnic, I., Lindemann, D., Foamy virus budding and release. Viruses 5 (2013), 1075–1098.
71. [71] Prevelige, P.E. Jr., Thomas, D., King, J., Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells. Biophys. J. 64 (1993), 824–835.
72. [72] Cadena-Nava, R.D., Comas-Garcia, M., Garmann, R.F., Rao, A.L., Knobler, C.M., Gelbart, W.M., Self-assembly of viral capsid protein and RNA molecules of different sizes: requirement for a specific high protein/RNA mass ratio. J. Virol. 86 (2012), 3318–3326.
73. [73] Chen, D.H., Baker, M.L., Hryc, C.F., DiMaio, F., Jakana, J., Wu, W.M., Dougherty, M., Haase-Pettingell, C., Schmid, M.F., Jiang, W., Baker, D., King, J.A., Chiu, W., Structural basis for scaffolding-mediated assembly and maturation of a dsDNA virus. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 1355–1360.
74. [74] Welsch, S., Muller, B., Krausslich, H.G., More than one door — budding of enveloped viruses through cellular membranes. FEBS Lett. 581 (2007), 2089–2097.
75. [75] Stroh, L.J., Stehle, T., Glycan engagement by viruses: receptor switches and specificity. Ann. Rev. Virol. 1 (2014), 285–306.
76. [76] Viswanathan, K., Chandrasekaran, A., Srinivasan, A., Raman, R., Sasisekharan, V., Sasisekharan, R., Glycans as receptors for influenza pathogenesis. Glycoconj. J. 27 (2010), 561–570.
77. [77] Geijtenbeek, T.B.H., Kwon, D.S., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C.F., Middel, J., Cornelissen, I.L.M.H.A., Nottet, H.S.L.M., KewalRamani, V.N., Littman, D.R., Figdor, C.G., van Kooyk, Y., DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000), 587–597.
78. [78] Turville, S.G., Santos, J.J., Frank, I., Cameron, P.U., Wilkinson, J., Miranda-Saksena, M., Dable, J., Stossel, H., Romani, N., Piatak, M., Lifson, J.D., Pope, M., Cunningham, A.L., Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 (2004), 2170–2179.
79. [79] Gluska, S., Zahavi, E.E., Chein, M., Gradus, T., Bauer, A., Finke, S., Perlson, E., Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathog., 10, 2014.
80. [80] Baird, B., Receptors — models for binding, trafficking and signalling. — Lauffenburger, Da, Linderman, JJ. Nature, 368, 1994, 702.
81. [81] Mammen, M., Choi, S.K., Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Chem. Int., 1998.
82. [82] Ewers, H., Romer, W., Smith, A.E., Bacia, K., Dmitrieff, S., Chai, W.G., Mancini, R., Kartenbeck, J., Chambon, V., Berland, L., Oppenheim, A., Schwarzmann, G., Feizi, T., Schwille, P., Sens, P., Helenius, A., Johannes, L., GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell Biol. 12 (2010), 11–U36.
83. [83] Stewart, P.L., Nemerow, G.R., Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 15 (2007), 500–507.
84. [84] Eierhoff, T., Hrincius, E.R., Rescher, U., Ludwig, S., Ehrhardt, C., The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog., 6, 2010.
85. [85] Cocquerel, L., Voisset, C., Dubuisson, J., Hepatitis C virus entry: potential receptors and their biological functions. J. Gen. Virol. 87 (2006), 1075–1084.
86. [86] Landau, N.R., Warton, M., Littman, D.R., The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of Cd4. Nature 334 (1988), 159–162.
87. [87] Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996), 872–877.
88. [88] Deng, H.K., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., DiMarzio, P., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schall, T.J., Littman, D.R., Landau, N.R., Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 (1996), 661–666.
89. [89] Rey, F.A., Molecular gymnastics at the herpesvirus surface. EMBO Rep. 7 (2006), 1000–1005.
90. [90] Marsh, M., Membrane Trafficking in Viral Replication. 2006, Springer, Berlin Heidelberg.
91. [91] Weissenhorn, W., Hinz, A., Gaudin, Y., Virus membrane fusion. FEBS Lett. 581 (2007), 2150–2155.
92. [92] Harrison, S.C., Viral membrane fusion. Nat. Struct. Mol. Biol. 15 (2008), 690–698.
93. [93] Hutt-Fletcher, L.M., Epstein–Barr virus entry. J. Virol. 81 (2007), 7825–7832.
94. [94] Laliberte, J.P., Weisberg, A.S., Moss, B., The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog., 7, 2011.
95. [95] Vancini, R., Hernandez, R., Brown, D., Chapter two — alphavirus entry into host cells. Klasse, P.J., (eds.) Progress in Molecular Biology and Translational Science, 2015, Academic Press, 33–62.
96. [96] Mercer, J., Schelhaas, M., Helenius, A., Virus entry by endocytosis. Annu. Rev. Biochem. 79 (2010), 803–833.
97. [97] Sorkin, A., Puthenveedu, M.A., Clathrin-mediated Endocytosis. 2013, Springer New York, New York, NY, 1–31.
98. [98] McMahon, H.T., Boucrot, E., Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12 (2011), 517–533.
99. [99] Liu, Y., Joo, K.I., Wang, P., Endocytic processing of adeno-associated virus type 8 vectors for transduction of target cells. Gene Ther. 20 (2013), 308–317.
100. [100] Mayor, S., Pagano, R.E., Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8 (2007), 603–612.
101. [101] Pelkmans, L., Helenius, A., Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15 (2003), 414–422.
102. [102] Parton, R.G., Simons, K., The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8 (2007), 185–194.
103. [103] Wadia, J.S., Stan, R.V., Dowdy, S.F., Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004), 310–315.
104. [104] Reyes-Reyes, E.M., Teng, Y., Bates, P.J., A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Res. 70 (2010), 8617–8629.
105. [105] Mayor, S., Pagano, R.E., Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8 (2007), 603–612.
106. [106] Boulant, S., Stanifer, M., Lozach, P.-Y., Dynamics of virus–receptor interactions in virus binding, signaling, and endocytosis. Viruses 7 (2015), 2794–2815.
107. [107] Lakadamyali, M., Rust, M.J., Zhuang, X., Endocytosis of influenza viruses. Microbes Infect. Inst. Pasteur 6 (2004), 929–936.
108. [108] Sun, X., Whittaker, G.R., Entry of influenza virus. Pöhlmann, S., Simmons, G., (eds.) Viral Entry Into Host Cells, 2013, Springer New York, New York, NY, 72–82.
109. [109] Mudhakir, D., Harashima, H., Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J., 11, 2009, 65.
110. [110] Rossman, J.S., Leser, G.P., Lamb, R.A., Filamentous influenza virus enters cells via macropinocytosis. J. Virol. 86 (2012), 10950–10960.
111. [111] Cureton, D.K., Massol, R.H., Whelan, S.P.J., Kirchhausen, T., The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis. PLoS Pathog., 6, 2010, e1001127.
112. [112] Whitbeck, J.C., Foo, C.-H., Ponce de Leon, M., Eisenberg, R.J., Cohen, G.H., Vaccinia virus exhibits cell-type-dependent entry characteristics. Virology 385 (2009), 383–391.
113. [113] Endocytic components: identification and characterization. Subcell. Biochem., 19, 1993, 1–254.
114. [114] Lagache, T., Danos, O., Holcman, D., Modeling the step of endosomal escape during cell infection by a nonenveloped virus. Biophys. J. 102 (2012), 980–989.
115. [115] Agosto, M.A., Ivanovic, T., Nibert, M.L., Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl. Acad. Sci. 103 (2006), 16496–16501.
116. [116] Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R., Sastry, M., Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21 (2005), 10644–10654.
117. [117] Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004), 313–319.
118. [118] Zhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J.H., Baker, T.S., Kuhn, R.J., Rossmann, M.G., Conformational changes of the flavivirus E glycoprotein. Structure 12 (2004), 1607–1618.
119. [119] Xu, R., Wilson, I.A., Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J. Virol. 85 (2011), 5172–5182.
120. [120] Skehel, J.J., Wiley, D.C., Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000), 531–569.
121. [121] Tse, F.W., Iwata, A., Almers, W., Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J. Cell Biol. 121 (1993), 543–552.
122. [122] Anderluh, G., Lakey, J.H., Proteins: Membrane Binding and Pore Formation. 2011, Springer Science & Business Media.
123. [123] Sánchez-Eugenia, R., Goikolea, J., Gil-Cartón, D., Sánchez-Magraner, L., Guérin, D.M.A., Triatoma virus recombinant VP4 protein induces membrane permeability through dynamic pores. J. Virol. 89 (2015), 4645–4654.
124. [124] Maier, O., Galan, D.L., Wodrich, H., Wiethoff, C.M., An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 402 (2010), 11–19.
125. [125] Tesar, M., Jia, X.-y., Summers, D.F., Ehrenfeld, E., Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology 194 (1993), 616–626.
126. [126] Capecchi, M.R., High-efficiency transformation by direct micro-injection of DNA into cultured mammalian-cells. Cell 22 (1980), 479–488.
127. [127] Berka, U., Hamann, M.V., Lindemann, D., Early events in foamy virus—host interaction and intracellular trafficking. Viruses 5 (2013), 1055–1074.
128. [128] Ploubidou, A., Moreau, V., Ashman, K., Reckmann, I., Gonzalez, C., Way, M., Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J. 19 (2000), 3932–3944.
129. [129] Ye, G.J., Vaughan, K.T., Vallee, R.B., Roizman, B., The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J. Virol. 74 (2000), 1355–1363.
130. [130] Kelkar, S.A., Pfister, K.K., Crystal, R.G., Leopold, P.L., Cytoplasmic dynein mediates adenovirus binding to microtubules. J. Virol. 78 (2004), 10122–10132.
131. [131] Leopold, P.L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K.K., Rodriguez-Boulan, E., Crystal, R.G., Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11 (2000), 151–165.
132. [132] Xiao, P.J., Samulski, R.J., Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network. J. Virol. 86 (2012), 10462–10473.
133. [133] Aniento, F., Cytoplasmic dynein-dependent vesicular transport from early to late endosomes (vol 123, pg 1373, 1993). J. Cell Biol., 124, 1994, 397.
134. [134] Fassati, A., Goff, S.P., Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75 (2001), 3626–3635.
135. [135] Levine, A.J., Viruses: A Scientific American Library Book. 1992, W.H. Freeman and Co, New York.
136. [136] Lieber, A., Kay, M.A., Li, Z.Y., Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells. J. Virol. 74 (2000), 721–734.
137. [137] Kobiler, O., Drayman, N., Butin-Israeli, V., Oppenheim, A., Virus strategies for passing the nuclear envelope barrier. Nucleus-Austin 3 (2012), 526–539.
138. [138] Weinberg, J.B., Matthews, T.J., Cullen, B.R., Malim, M.H., Productive human-immunodeficiency-virus type-1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174 (1991), 1477–1482.
139. [139] Pfeifer, A., Verma, I.M., Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet. 2 (2001), 177–211.
140. [140] Mosammaparast, N., Pemberton, L.F., Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol. 14 (2004), 547–556.
141. [141] Lange, A., Mills, R.E., Lange, C.J., Stewart, M., Devine, S.E., Corbett, A.H., Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282 (2007), 5101–5105.
142. [142] Kumar, S., Saradhi, M., Chaturvedi, N.K., Tyagi, R.K., Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol. Cell. Endocrinol. 246 (2006), 147–156.
143. [143] Macara, I.G., Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65 (2001), 570–594.
144. [144] Weis, K., Nucleocytoplasmic transport: cargo trafficking across the border. Curr. Opin. Cell Biol. 14 (2002), 328–335.
145. [145] Weber, F., Kochs, G., Gruber, S., Haller, O., A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology 250 (1998), 9–18.
146. [146] Bukrinsky, M.I., Haggerty, S., Dempsey, M.P., Sharova, N., Adzhubei, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., Stevenson, M., A nuclear-localization signal within HIV-1 matrix protein that governs infection of nondividing cells. Nature 365 (1993), 666–669.
147. [147] Gallay, P., Swingler, S., Song, J.P., Bushman, F., Trono, D., HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83 (1995), 569–576.
148. [148] Heinzinger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani, V., Lee, M.A., Gendelman, H.E., Ratner, L., Stevenson, M., Emerman, M., The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 7311–7315.
149. [149] Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M., Naldini, L., Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet., 25, 2000, 217-+.
150. [150] Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., Charneau, P., HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101 (2000), 173–185.
151. [151] Fay, N., Panté, N., Nuclear entry of DNA viruses. Front. Microbiol., 6, 2015, 467.
152. [152] Cohen, S., Au, S., Panté, N., How viruses access the nucleus. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 1813 (2011), 1634–1645.
153. [153] Hennig, T., O'Hare, P., Viruses and the nuclear envelope. Curr. Opin. Cell Biol. 34 (2015), 113–121.
154. [154] Flatt, J.W., Greber, U.F., Misdelivery at the nuclear pore complex—stopping a virus dead in its tracks. Cells 4 (2015), 277–296.
155. [155] Fay, N., Panté, N., Old foes, new understandings: nuclear entry of small non-enveloped DNA viruses. Curr. Opin. Virol. 12 (2015), 59–65.
156. [156] Whittaker, G.R., Kann, M., Helenius, A., Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16 (2000), 627–651.
157. [157] Trotman, L.C., Mosberger, N., Fornerod, M., Stidwill, R.P., Greber, U.F., Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3 (2001), 1092–1100.
158. [158] Ojala, P.M., Sodeik, B., Ebersold, M.W., Kutay, U., Helenius, A., Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol. 20 (2000), 4922–4931.
159. [159] Le Sage, V., Mouland, A.J., Viral subversion of the nuclear pore complex. Viruses 5 (2013), 2019–2042.
160. [160] Kemler, I., Whittaker, G., Helenius, A., Nuclear import of microinjected influenza-virus ribonucleoproteins. Virology 202 (1994), 1028–1033.
161. [161] Johnson, J.S., Li, C.W., DiPrimio, N., Weinberg, M.S., McCown, T.J., Samulski, R.J., Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. J. Virol. 84 (2010), 8888–8902.
162. [162] Hoover-Litty, H., Greve, J.M., Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J. Virol. 67 (1993), 390–397.
163. [163] Racaniello, V.R., The poliovirus receptor: a hook, or an unzipper?. Structure 4 (1996), 769–773.
164. [164] Wang, X., Peng, W., Ren, J., Hu, Z., Xu, J., Lou, Z., Li, X., Yin, W., Shen, X., Porta, C., Walter, T.S., Evans, G., Axford, D., Owen, R., Rowlands, D.J., Wang, J., Stuart, D.I., Fry, E.E., Rao, Z., A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 19 (2012), 424–429.
165. [165] Nurani, G., Lindqvist, B., Casasnovas, J.M., Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments. J. Virol. 77 (2003), 11985–11991.
166. [166] Kilcher, S., Schmidt, F.I., Schneider, C., Kopf, M., Helenius, A., Mercer, J., siRNA screen of early poxvirus genes identifies the AAA + ATPase D5 as the virus genome-uncoating factor. Cell Host Microbe 15 (2014), 103–112.
167. [167] Greber, U.F., Willetts, M., Webster, P., Helenius, A., Stepwise dismantling of adenovirus-2 during entry into cells. Cell 75 (1993), 477–486.
168. [168] Nakano, M.Y., Boucke, K., Suomalainen, M., Stidwill, R.P., Greber, U.F., The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 74 (2000), 7085–7095.
169. [169] Puntener, D., Engelke, M.F., Ruzsics, Z., Strunze, S., Wilhelm, C., Greber, U.F., Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J. Virol. 85 (2011), 481–496.
170. [170] Wiethoff, C.M., Wodrich, H., Gerace, L., Nemerow, G.R., Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79 (2005), 1992–2000.
171. [171] Bremner, K.H., Scherer, J., Yi, J.L., Vershinin, M., Gross, S.P., Vallee, R.B., Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6 (2009), 523–535.
172. [172] Li, S., Sieben, C., Ludwig, K., Hofer, C.T., Chiantia, S., Herrmann, A., Eghiaian, F., Schaap, I.A.T., pH-controlled two-step uncoating of influenza virus. Biophys. J. 106 (2014), 1447–1456.
173. [173] Kawano, M.A., Xing, L., Tsukamoto, H., Inoue, T., Handa, H., Cheng, R.H., Calcium bridge triggers capsid disassembly in the cell entry process of simian virus 40. J. Biol. Chem. 284 (2009), 34703–34712.
174. [174] Grewe, C., Beck, A., Gelderblom, H.R., HIV — early virus–cell interactions. J. Acquir. Immune Defic. Syndr. 3 (1990), 965–974.
175. [175] Karageorgos, L., Li, P., Burrell, C., Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retrovir. 9 (1993), 817–823.
176. [176] Heinzinger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani, V., Lee, M.A., Gendelman, H.E., Ratner, L., Stevenson, M., Emerman, M., The VPR protein of human-immunodeficiency-virus type-1 influences nuclear-localization of viral nucleic-acids in nondividing host-cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 7311–7315.
177. [177] Fassati, A., Goff, S.P., Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75 (2001), 3626–3635.
178. [178] Warrilow, D., Tachedjian, G., Harrich, D., Maturation of the HIV reverse transcription complex: putting the jigsaw together. Rev. Med. Virol. 19 (2009), 324–337.
179. [179] McDonald, D., Vodicka, M.A., Lucero, G., Svitkina, T.M., Borisy, G.G., Emerman, M., Hope, T.J., Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159 (2002), 441–452.
180. [180] Goff, S.P., Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J Gene Med 3 (2001), 517–528.
181. [181] Arhel, N., Revisiting HIV-1 uncoating. Retrovirology, 7, 2010, 96.
182. [182] Hulme, A.E., Perez, O., Hope, T.J., Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9975–9980.
183. [183] Xu, H., Franks, T., Gibson, G., Huber, K., Rahm, N., Strambio De Castillia, C., Luban, J., Aiken, C., Watkins, S., Sluis-Cremer, N., Ambrose, Z., Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology, 10, 2013, 70.
184. [184] Lahaye, X., Satoh, T., Gentili, M., Cerboni, S., Conrad, C., Hurbain, I., El Marjou, A., Lacabaratz, C., Lelievre, J.D., Manel, N., The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39 (2013), 1132–1142.
185. [185] Rasaiyaah, J., Tan, C.P., Fletcher, A.J., Price, A.J., Blondeau, C., Hilditch, L., Jacques, D.A., Selwood, D.L., James, L.C., Noursadeghi, M., Towers, G.J., HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503 (2013), 402–405.
186. [186] Ambrose, Z., Aiken, C., HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. Virology 454 (2014), 371–379.
187. [187] Yufenyuy, E.L., Aiken, C., The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid. Retrovirology, 10, 2013, 29.
188. [188] Byeon, I.J.L., Meng, X., Jung, J.W., Zhao, G.P., Yang, R.F., Ahn, J.W., Shi, J., Concel, J., Aiken, C., Zhang, P.J., Gronenborn, A.M., Structural convergence between cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139 (2009), 780–790.
189. [189] Pornillos, O., Ganser-Pornillos, B.K., Yeager, M., Atomic-level modelling of the HIV capsid. Nature, 469, 2011, 424-+.
190. [190] Obal, G., Trajtenberg, F., Carrion, F., Tome, L., Larrieux, N., Zhang, X., Pritsch, O., Buschiazzo, A., Structural virology. Conformational plasticity of a native retroviral capsid revealed by x-ray crystallography. Science 349 (2015), 95–98.
191. [191] Wynne, S.A., Crowther, R.A., Leslie, A.G.W., The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3 (1999), 771–780.
192. [192] Agarwal, S., Zhang, Y., Maji, S., Greiner, A., PDMAEMA based gene delivery materials. Mater Today 15 (2012), 388–393.
193. [193] Carlisle, R.C., Fisher, K.D., Parker, A.L., Seymour, L.W., Systems for gene delivery based on combination of viral and non-viral vectors. Nato Adv. Sci. I A-Lif 323 (2000), 117–125.
194. [194] Pigeon, L., Goncalves, C., Pichon, C., Midoux, P., Building up artificial virus for gene delivery. Hum. Gene Ther. 26 (2015), A79–A80.
195. [195] Xu, P.S., Li, S.Y., Li, Q., Zhan, Y.H., Ren, J., Radosz, M., Shen, Y.Q., Polymeric artificial virus for gene delivery. Abstr. Pap. Am. Chem. Soc., 231, 2006.
196. [196] Barran-Berdon, A.L., Munoz-Ubeda, M., Aicart-Ramos, C., Perez, L., Infante, M.-R., Castro-Hartmann, P., Martin-Molina, A., Aicart, E., Junquera, E., Ribbon-type and cluster-type lipoplexes constituted by a chiral lysine based cationic gemini lipid and plasmid DNA. Soft Matter 8 (2012), 7368–7380.
197. [197] Navarro, G., de ILarduya, C.T., Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomedicine 5 (2009), 287–297.
198. [198] de Ilarduya, C.T., Sun, Y., Duezguenes, N., Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Sci. 40 (2010), 159–170.
199. [199] Pector, V., Backmann, J., Maes, D., Vandenbranden, M., Ruysschaert, J.M., Biophysical and structural properties of DNA.diC(14)-amidine complexes. Influence of the DNA/lipid ratio. J. Biol. Chem. 275 (2000), 29533–29538.
200. [200] Elouahabi, A., Ruysschaert, J.M., Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11 (2005), 336–347.
201. [201] Ma, B.C., Zhang, S.B., Jiang, H.M., Zhao, B.D., Lv, H.T., Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J. Control. Release 123 (2007), 184–194.
202. [202] Sternberg, B., Sorgi, F.L., Huang, L., New structures in complex-formation between DNA and cationic liposomes visualized by freeze-fracture electron-microscopy. FEBS Lett. 356 (1994), 361–366.
203. [203] Koltover, I., Salditt, T., Safinya, C.R., Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. Biophys. J. 77 (1999), 915–924.
204. [204] Ewert, K.K., Zidovska, A., Ahmad, A., Bouxsein, N.F., Evans, H.M., McAllister, C.S., Samuel, C.E., Safinya, C.R., Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA. Top. Curr. Chem. 296 (2010), 191–226.
205. [205] Bouxsein, N.F., McAllister, C.S., Ewert, K.K., Samuel, C.E., Safinya, C.R., Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry-Us 46 (2007), 4785–4792.
206. [206] Forrest, M.L., Pack, D.W., On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Mol. Ther. 6 (2002), 57–66.
207. [207] Motta, S., Brocca, P., Del Favero, E., Rondelli, V., Cantu, L., Amici, A., Pozzi, D., Caracciolo, G., Nanoscale structure of protamine/DNA complexes for gene delivery. Appl. Phys. Lett., 102, 2013.
208. [208] Soltani, F., Sankian, M., Hatefi, A., Ramezani, M., Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene delivery. Int. J. Pharm. 441 (2013), 307–315.
209. [209] Gottschalk, S., Sparrow, J., Hauer, J., Mims, M., Leland, F., Woo, S., Smith, L., A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther. 3 (1996), 448–457.
210. [210] Khalil, I.A., Futaki, S., Niwa, M., Baba, Y., Kaji, N., Kamiya, H., Harashima, H., Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11 (2004), 636–644.
211. [211] Kwok, A., Hart, S.L., Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 7 (2011), 210–219.
212. [212] Tan, P.H., Yang, L.C., Shih, H.C., Lan, K.C., Cheng, J.T., Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12 (2005), 59–66.
213. [213] Patil, M.L., Zhang, M., Betigeri, S., Taratula, O., He, H., Minko, T., Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug. Chem. 19 (2008), 1396–1403.
214. [214] Endoh, T., Ohtsuki, T., Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv. Drug Deliv. Rev. 61 (2009), 704–709.
215. [215] Wang, Y.H., Hou, Y.W., Lee, H.J., An intracellular delivery method for siRNA by an arginine-rich peptide. J. Biochem. Biophys. Methods 70 (2007), 579–586.
216. [216] Simeoni, F., Morris, M.C., Heitz, F., Divita, G., Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31 (2003), 2717–2724.
217. [217] Schroeder, A., Levins, C.G., Cortez, C., Langer, R., Anderson, D.G., Lipid-based nanotherapeutics for siRNA delivery. J. Intern. Med. 267 (2010), 9–21.
218. [218] Kogure, K., Akita, H., Harashima, H., Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging. J. Control. Release 122 (2007), 246–251.
219. [219] Nakamura, Y., Kogure, K., Futaki, S., Harashima, H., Octaarginine-modified multifunctional envelope-type nano device for siRNA. J. Control. Release 119 (2007), 360–367.
220. [220] Kogure, K., Akita, H., Yamada, Y., Harashima, H., Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv. Drug Deliv. Rev. 60 (2008), 559–571.
221. [221] Akita, H., Kogure, K., Moriguchi, R., Nakamura, Y., Higashi, T., Nakamura, T., Serada, S., Fujimoto, M., Naka, T., Futaki, S., Harashima, H., Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J. Control. Release 143 (2010), 311–317.
222. [222] Yamauchi, J., Hayashi, Y., Kajimoto, K., Akita, H., Harashima, H., Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver. Biol. Pharm. Bull. 33 (2010), 926–929.
223. [223] Hatakeyama, H., Akita, H., Harashima, H., A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv. Drug Deliv. Rev. 63 (2011), 152–160.
224. [224] Kajimoto, K., Sato, Y., Nakamura, T., Yamada, Y., Harashima, H., Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo. J. Control. Release 190 (2014), 593–606.
225. [225] Yin, H.L., Mu, A.Z., Sun, Y., Yan, G.W., Wei, H.T., Ma, C., Sun, C.G., Preparation and evaluation of multifunctional envelope-type nano device loading siRNA. Artif. Cell. Nanomed. B 44 (2016), 20–26.
226. [226] Sakurai, Y., Hatakeyama, H., Sato, Y., Hyodo, M., Akita, H., Harashima, H., Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. Mol. Ther. 21 (2013), 1195–1203.
227. [227] Chen, L.S., Wang, M., Ou, W.C., Fung, C.Y., Chen, P.L., Chang, C.F., Huang, W.S., Wang, J.Y., Lin, P.Y., Chang, D., Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model. Gene Ther. 17 (2010), 1033–1041.
228. [228] Yang, Y.H., Ma, J., Song, Z.Y., Wu, M., HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett. 532 (2002), 36–44.
229. [229] Lim, Y.B., Lee, E., Yoon, Y.R., Lee, M.S., Lee, M., Filamentous artificial virus from a self-assembled discrete nanoribbon. Angew. Chem. Int. Ed. Eng. 47 (2008), 4525–4528.
230. [230] Ruff, Y., Moyer, T., Newcomb, C.J., Demeler, B., Stupp, S.I., Precision templating with DNA of a virus-like particle with peptide nanostructures. J. Am. Chem. Soc. 135 (2013), 6211–6219.
231. [231] Hernandez-Garcia, A., Kraft, D.J., Janssen, A.F., Bomans, P.H., Sommerdijk, N.A., Thies-Weesie, D.M., Favretto, M.E., Brock, R., de Wolf, F.A., Werten, M.W., Design and self-assembly of simple coat proteins for artificial viruses. Nat. Nanotechnol. 9 (2014), 698–702.
232. [232] Ni, R., Chau, Y., Structural mimics of viruses through peptide/DNA co-assembly. J. Am. Chem. Soc. 136 (2014), 17902–17905.
233. [233] Nollens, H.H., Jacobson, E.R., Gulland, F.M., Beusse, D.O., Bossart, G.D., Hernandez, J.A., Klein, P.A., Condit, R.C., Pathology and preliminary characterization of a parapoxvirus isolated from a California sea lion (Zalophus californianus). J Wildl Dis 42 (2006), 23–32.
234. [234] Okada, Y., Molecular assembly of tobacco mosaic virus in vitro. Adv. Biophys. 22 (1986), 95–149.
235. [235] Levine, R.M., Scott, C.M., Kokkoli, E., Peptide functionalized nanoparticles for nonviral gene delivery. Soft Matter 9 (2013), 985–1004.
236. [236] Son, S., Hwang, D.W., Singha, K., Jeong, J.H., Park, T.G., Lee, D.S., Kim, W.J., RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J. Control. Release 155 (2011), 18–25.
237. [237] Hwang, D.W., Son, S., Jang, J., Youn, H., Lee, S., Lee, D., Lee, Y.S., Jeong, J.M., Kim, W.J., Lee, D.S., A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 32 (2011), 4968–4975.
238. [238] Hussein, H.A.M., Walker, L.R., Abdel-Raouf, U.M., Desouky, S.A., Montasser, A.K.M., Akula, S.M., Beyond RGD: virus interactions with integrins. Arch. Virol. 160 (2015), 2669–2681.
239. [239] Danhier, F., Le Breton, A., Preat, V., RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol. Pharm. 9 (2012), 2961–2973.
240. [240] Phua, K.K.L., Towards targeted delivery systems: ligand conjugation strategies for mRNA nanoparticle tumor vaccines. J. Immunol. Res. 2015 (2015), 680620–680628.
241. [241] Wang, S., Dormidontova, E.E., Nanoparticle targeting using multivalent ligands: computer modeling. Soft Matter 7 (2011), 4435–4445.
242. [242] Wong, P.T., Tang, K., Coulter, A., Tang, S., Baker, J.R., Choi, S.K., Multivalent dendrimer vectors with DNA intercalation motifs for gene delivery. Biomacromolecules 15 (2014), 4134–4145.
243. [243] Lorenzer, C., Dirin, M., Winkler, A.-M., Baumann, V., Winkler, J., Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. J. Control. Release 203 (2015), 1–15.
244. [244] Wei, X., Chen, X., Ying, M., Lu, W., Brain tumor-targeted drug delivery strategies. Acta Pharm. Sin. B 4 (2014), 193–201.
245. [245] Wang, M., Hu, H., Sun, Y., Qiu, L., Zhang, J., Guan, G., Zhao, X., Qiao, M., Cheng, L., Cheng, L., Chen, D., A pH-sensitive gene delivery system based on folic acid-PEG-chitosan–PAMAM-plasmid DNA complexes for cancer cell targeting. Biomaterials 34 (2013), 10120–10132.
246. [246] Gaumet, M., Vargas, A., Gurny, R., Delie, F., Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69 (2008), 1–9.
247. [247] Barenholz, Y.C., Doxil® — the first FDA-approved nano-drug: lessons learned. J. Control. Release 160 (2012), 117–134.
248. [248] Falanga, A., Tarallo, R., Galdiero, E., Cantisani, M., Galdiero, M., Galdiero, S., Review of a viral peptide nanosystem for intracellular delivery. NANOP, 7, 2013, 071599.
249. [249] Trabulo, S., Cardoso, A.L., Mano, M., de Lima, M.C.P., Cell-penetrating peptides—mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 3 (2010), 961–993.
250. [250] Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., Harashima, H., Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43 (2004), 5618–5628.
251. [251] Bareford, L.A., Swaan, P.W., Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev. 59 (2007), 748–758.
252. [252] Madani, F., Lindberg, S., Langel, Ü., Futaki, S., Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys., 2011.
253. [253] Schmidt, N., Mishra, A., Lai, G.H., Wong, G.C.L., Arginine-rich cell-penetrating peptides. FEBS Lett. 584 (2010), 1806–1813.
254. [254] Cantini, L., Attaway, C.C., Butler, B., Andino, L.M., Sokolosky, M.L., Jakymiw, A., Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. PLoS ONE, 8, 2013, e73348.
255. [255] Ji, M., Li, P., Sheng, N., Liu, L., Pan, H., Wang, C., Cai, L., Ma, Y., Sialic acid-targeted nanovectors with phenylboronic acid-grafted polyethylenimine robustly enhance siRNA-based cancer therapy. ACS Appl. Mater. Interfaces 8 (2016), 9565–9576.
256. [256] Hayer, A., Stoeber, M., Ritz, D., Engel, S., Meyer, H.H., Helenius, A., Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191 (2010), 615–629.
257. [257] Mitragotri, S., Lahann, J., Physical approaches to biomaterial design. Nat. Mater. 8 (2009), 15–23.
258. [258] Chu, Z., Zhang, S., Zhang, B., Zhang, C., Fang, C.-Y., Rehor, I., Cigler, P., Chang, H.-C., Lin, G., Liu, R., Li, Q., Unambiguous observation of shape effects on cellular fate of nanoparticles. Sci. Rep., 4, 2014, 4495.
259. [259] Florez, L., Herrmann, C., Cramer, J., Hauser, C., Koynov, K., Landfester, K., Crespy, D., Mailander, V., How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. Small 8 (2012), 2222–2230.
260. [260] Martens, T.F., Remaut, K., Demeester, J., De Smedt, S.C., Braeckmans, K., Intracellular delivery of nanomaterials: how to catch endosomal escape in the act. Nano Today, 2014.
261. [261] Varkouhi, A.K., Scholte, M., Storm, G., Haisma, H.J., Endosomal escape pathways for delivery of biologicals. J. Control. Release 151 (2011), 220–228.
262. [262] Oliveira, S., van Rooy, I., Kranenburg, O., Storm, G., Schiffelers, R.M., Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm. 331 (2007), 211–214.
263. [263] Kwon, E.J., Liong, S., Pun, S.H., A truncated HGP peptide sequence that retains endosomolytic activity and improves gene delivery efficiencies. Mol Pharm. 7 (2010), 1260–1265.
264. [264] Kwon, E.J., Bergen, J.M., Pun, S.H., Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjug. Chem. 19 (2008), 920–927.
265. [265] Li, W., Nicol, F., Szoka, F.C. Jr., GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56 (2004), 967–985.
266. [266] Angeles-Boza, A.M., Erazo-Oliveras, A., Lee, Y.-J., Pellois, J.-P., Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans. Bioconjug. Chem. 21 (2010), 2164–2167.
267. [267] Dominska, M., Dykxhoorn, D.M., Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 123 (2010), 1183–1189.
268. [268] El-Sayed, A., Futaki, S., Harashima, H., Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J. 11 (2009), 13–22.
269. [269] Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., Pellois, J.-P., Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 5 (2012), 1177–1209.
270. [270] Shete, H.K., Prabhu, R.H., Patravale, V.B., Endosomal escape: a bottleneck in intracellular delivery. J. Nanosci. Nanotechnol. 14 (2014), 460–474.
271. [271] Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., Epstein-Barash, H., Zhang, L., Koteliansky, V., Fitzgerald, K., Fava, E., Bickle, M., Kalaidzidis, Y., Akinc, A., Maier, M., Zerial, M., Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31 (2013), 638–646.
272. [272] Hama, S., Akita, H., Ito, R., Mizuguchi, H., Hayakawa, T., Harashima, H., Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther. 13 (2006), 786–794.
273. [273] Ross, N.L., Munsell, E.V., Sabanayagam, C., Sullivan, M.O., Histone-targeted polyplexes avoid endosomal escape and enter the nucleus during postmitotic redistribution of ER membranes. Mol. Ther. Nucleic Acids, 4, 2015, e226.
274. [274] Lukacs, G.L., Haggie, P., Seksek, O., Lechardeur, D., Freedman, N., Verkman, A.S., Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275 (2000), 1625–1629.
275. [275] Khalil, I.A., Kogure, K., Futaki, S., Harashima, H., High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 (2006), 3544–3551.
276. [276] Doyle, S.R., Chan, C.K., Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells. Genet. Vaccines Ther., 5, 2007, 11.
277. [277] Lechardeur, D., Sohn, K.J., Haardt, M., Joshi, P.B., Monck, M., Graham, R.W., Beatty, B., Squire, J., O'Brodovich, H., Lukacs, G.L., Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6 (1999), 482–497.
278. [278] Scherer, J., Vallee, R.B., Adenovirus Recruits Dynein by an Evolutionary Novel Mechanism Involving Direct Binding to pH-Primed Hexon. Viruses-Basel 3 (2011), 1417–1431.
279. [279] Leopold, P.L., Pfister, K.K., Viral strategies for intracellular trafficking: motors and microtubules. Traffic 7 (2006), 516–523.
280. [280] Carter, A.P., Garbarino, J.E., Wilson-Kubalek, E.M., Shipley, W.E., Cho, C., Milligan, R.A., Vale, R.D., Gibbons, I.R., Structure and functional role of dynein's microtubule-binding domain. Science 322 (2008), 1691–1695.
281. [281] Caviston, J.P., Holzbaur, E.L.F., Microtubule motors at the intersection of trafficking and transport. Trends Cell Biol. 16 (2006), 530–537.
282. [282] Pigeon, L., Goncalves, C., Gosset, D., Pichon, C., Midoux, P., An E3-14.7K Peptide that Promotes Microtubules-Mediated Transport of Plasmid DNA Increases Polyplexes Transfection Efficiency. Small 9 (2013), 3845–3851.
283. [283] Akita, H., Enoto, K., Tanaka, H., Harashima, H., Particle tracking analysis for the intracellular trafficking of nanoparticles modified with African swine fever virus protein p54-derived peptide. Mol. Ther. 21 (2013), 309–317.
284. [284] Cartier, R., Reszka, R., Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. 9 (2002), 157–167.
285. [285] Jenkins, Y., McEntee, M., Weis, K., Greene, W.C., Characterization of HIV-1 Vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143 (1998), 875–885.
286. [286] Nakielny, S., Dreyfuss, G., Transport of proteins and RNAs in and out of the nucleus. Cell 99 (1999), 677–690.
287. [287] Brohawn, S.G., Partridge, J.R., Whittle, J.R.R., Schwartz, T.U., The nuclear pore complex has entered the atomic age. Structure 17 (2009), 1156–1168.
288. [288] Talsma, S.S., Babensee, J.E., Murthy, N., Williams, I.R., Development and in vitro validation of a targeted delivery vehicle for DNA vaccines. J. Control. Release 112 (2006), 271–279.
289. [289] Zanta, M.A., Belguise-Valladier, P., Behr, J.P., Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 91–96.
290. [290] Collins, E., Birchall, J.C., Williams, J.L., Gumbleton, M., Nuclear localisation and pDNA condensation in non-viral gene delivery. J. Gene Med. 9 (2007), 265–274.
291. [291] Chen, B., Pan, R., Askhatova, D., Chen, P., Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide. Int. J. Nanomedicine 10 (2015), 3303–3314.
292. [292] Kim, H., Kim, H.A., Bae, Y.M., Choi, J.S., Min, M., Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes. J. Gene Med. 11 (2009), 515–522.
293. [293] Dean, D.A., Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. 230 (1997), 293–302.
294. [294] Wildeman, A.G., Regulation of Sv40 early gene-expression. Biochem. Cell Biol., 66, 1988, 567-&.
295. [295] Tao, Y.H., Han, J.F., Dou, H.Y., Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study. J. Mater. Chem. 22 (2012), 11808–11815.
296. [296] McCall, R.L., Householder, K.T., Chung, E.P., Sirianni, R.W., Pathogen-derived targets for the delivery of chemotherapeutics to the brain. Cancer Res., 74, 2014.
297. [297] Rapoport, M., Lorberboum-Galski, H., TAT-based drug delivery system—new directions in protein delivery for new hopes?. Expert Opin. Drug Deliv. 6 (2009), 453–463.
298. [298] Lin, K., Roosinovich, E., Ma, B., Hung, C.-F., Wu, T.C., Therapeutic HPV DNA vaccines. Immunol. Res. 47 (2010), 86–112.
299. [299] Midoux, P., Pichon, C., Yaouanc, J.-J., Jaffrès, P.-A., Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 157 (2009), 166–178.
300. [300] Tu, Y., Kim, J.-s., A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes. J. Gene Med. 10 (2008), 646–654.
301. [301] Kwon, E.J., Bergen, J.M., Park, I.K., Pun, S.H., Peptide-modified vectors for nucleic acid delivery to neurons. J. Control. Release 132 (2008), 230–235.
302. [302] Oliveira, S., van Rooy, I., Kranenburg, O., Storm, G., Schiffelers, R.M., Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm. 331 (2007), 211–214.
303. [303] Mastrobattista, E., Koning, G.A., van Bloois, L., Filipe, A.C.S., Jiskoot, W., Storm, G., Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 277 (2002), 27135–27143.
304. [304] Haryanto, A., Schmitz, A., Rabe, B., Gassert, E., Vlachou, A., Kann, M., Analysis of the nuclear localization signal of the hepatitis B virus capsid. Int. Res. J. Biochem. Bioinform. 2 (2012), 174–185.
305. [305] Yeh, C.-T., Liaw, Y., Ou, J.-H., The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport. J. Virol. 64 (1990), 6141–6147.
306. [306] Murray, K.D., Etheridge, C.J., Shah, S.I., Matthews, D.A., Russell, W., Gurling, H.M.D., Miller, A.D., Enhanced cationic liposome-mediated transfection using the DNA-binding peptide μ (mu) from the adenovirus core. Gene Ther., 8, 2001.
307. [307] Schneider, S., Lenz, D., Holzer, M., Palme, K., Suss, R., Intracellular FRET analysis of lipid/DNA complexes using flow cytometry and fluorescence imaging techniques. J. Control. Release 145 (2010), 289–296.
308. [308] Dean, D.A., Strong, D.D., Zimmer, W.E., Nuclear entry of nonviral vectors. Gene Ther. 12 (2005), 881–890.
309. [309] Cohen, R.N., van der Aa, M.A.E.M., Macaraeg, N., Lee, A.P., Szoka, F.C., Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection (vol 135, pg 166, 2009). J. Control. Release, 138, 2009, 185.
310. [310] Hama, S., Akita, H., Iida, S., Mizuguchi, H., Harashima, H., Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex. Nucleic Acids Res 35 (2007), 1533–1543.
311. [311] Schaffer, D.V., Fidelman, N.A., Dan, N., Lauffenburger, D.A., Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67 (2000), 598–606.
312. [312] Breuzard, G., Tertil, M., Goncalves, C., Cheradame, H., Geguan, P., Pichon, C., Midoux, P., Nuclear delivery of N kappa B-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging. Nucleic Acids Res., 36, 2008.
313. [313] Dheur, S., Dias, N., Van Aerschot, A., Herdewijn, P., Bettinger, T., Remy, J.S., Helene, C., Saison-Behmoaras, E.T., Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleolides. Antisense Nucleic Acid Drug Dev. 9 (1999), 515–525.
314. [314] Kim, Y.H., Park, J.H., Lee, M., Kim, Y.H., Park, T.G., Kim, S.W., Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J. Control. Release 103 (2005), 209–219.
315. [315] Shim, M.S., Kwon, Y.J., Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine. Biomacromolecules 9 (2008), 444–455.
316. [316] Shim, M.S., Kwon, Y.J., Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine. J. Control. Release 133 (2009), 206–213.
317. [317] Shim, M.S., Kwon, Y.J., Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery. Bioconjug. Chem. 20 (2009), 488–499.
318. [318] Zhu, M.Z., Wu, Q.H., Zhang, G.S., Ren, T., Liu, D.X., Guo, Q.X., Synthesis and evaluation of cationic lipids bearing cholesteryl groups for gene delivery in vitro. Bull. Chem. Soc. Jpn. 75 (2002), 2207–2213.
319. [319] Aissaoui, A., Martin, B., Kan, E., Oudrhiri, N., Hauchecorne, M., Vigneron, J.P., Lehn, J.M., Lehn, P., Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. J. Med. Chem. 47 (2004), 5210–5223.
320. [320] Boomer, J.A., Thompson, D.H., Sullivan, S.M., Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer. Pharm. Res. 19 (2002), 1292–1301.
321. [321] Chen, H.G., Zhang, H.Z., McCallum, C.M., Szoka, F.C., Guo, X., Unsaturated cationic ortho esters for endosome permeation in gene delivery. J. Med. Chem. 50 (2007), 4269–4278.
322. [322] Choi, J.S., MacKay, J.A., Szoka, F.C., Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization. Bioconjug. Chem. 14 (2003), 420–429.
323. [323] Roosjen, A., Smisterova, J., Driessen, C., Anders, J.T., Wagenaar, A., Hoekstra, D., Hulst, R., Engberts, J.B.F.N., Synthesis and characteristics of biodegradable pyridinium amphiphiles used for in vitro DNA delivery. Eur. J. Org. Chem., 2002, 1271–1277.
324. [324] Prata, C.A.H., Zhao, Y.X., Barthelemy, P., Li, Y.G., Luo, D., McIntosh, T.J., Lee, S.J., Grinstaff, M.W., Charge-reversal amphiphlies for gene delivery. J. Am. Chem. Soc. 126 (2004), 12196–12197.
325. [325] Lin, Y.L., Jiang, G.H., Birrell, L.K., El-Sayed, M.E.H., Degradable, pH-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acids. Biomaterials 31 (2010), 7150–7166.
326. [326] Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., Kataoka, K., Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile ss-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127 (2005), 1624–1625.
327. [327] Oupicky, D., Parker, A.L., Seymour, L.W., Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. J. Am. Chem. Soc. 124 (2002), 8–9.
328. [328] Read, M.L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S.S., Oupicky, D., Barrett, L.B., Spice, R., Kendall, M., Berry, M., Preece, J.A., Logan, A., Seymour, L.W., A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res., 33, 2005, e86.
329. [329] Gosselin, M.A., Guo, W.J., Lee, R.J., Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12 (2001), 989–994.
330. [330] Cavallaro, G., Campisi, M., Licciardi, M., Ogris, M., Giammona, G., Reversibly stable thiopolyplexes for intracellular delivery of genes. J. Control. Release 115 (2006), 322–334.
331. [331] McKenzie, D.L., Smiley, E., Kwok, K.Y., Rice, K.G., Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug. Chem. 11 (2000), 901–909.
332. [332] Read, M.L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S.S., Oupicky, D., Barrett, L.B., Spice, R., Kendall, M., Berry, M., Preece, J.A., Logan, A., Seymour, L.W., A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res., 33, 2005.
333. [333] Burnett, J.C., Rossi, J.J., Tiemann, K., Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol. J. 6 (2011), 1130–1146.
334. [334] Li, S., Tseng, W.C., Stolz, D.B., Wu, S.P., Watkins, S.C., Huang, L., Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 6 (1999), 585–594.
335. [335] Son, K.K., Tkach, D., Rosenblatt, J., Delipidated serum abolishes the inhibitory effect of serum on in vitro liposome-mediated transfection. Biochim. Biophys. Acta Biomembr. 1511 (2001), 201–205.
336. [336] Waldmann, M., Jirmann, R., Hoelscher, K., Wienke, M., Niemeyer, F.C., Rehders, D., Meyer, B., A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza. J. Am. Chem. Soc. 136 (2014), 783–788.